Dice Therapeutics Inc
(DICE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2017 | 12-2006 | |
| Sales | 0 | 1,125 | 863 | 0 | 0 |
| Gross Profit | N/A | 1,125 | 863 | N/A | N/A |
| Operating Expenses | 88,221 | 48,728 | 24,584 | 0 | 0 |
| Operating Income | -88,221 | -47,603 | -23,721 | N/A | N/A |
| Interest Expense | 679 | 174 | 13 | 0 | 0 |
| Other Income | 5,013 | -1,182 | -5 | 0 | 0 |
| Pre-tax Income | -83,887 | -48,959 | -23,739 | 0 | 0 |
| Net Income Continuous | -83,887 | -48,959 | -23,739 | N/A | N/A |
| Net Income | $-83,887 | $-48,959 | $-23,739 | $N/A | $N/A |
| EPS Basic Total Ops | -2.13 | -3.95 | -10.56 | N/A | N/A |
| EPS Basic Continuous Ops | -2.13 | -3.95 | -10.56 | N/A | N/A |
| EPS Diluted Total Ops | -2.13 | -3.95 | -10.56 | N/A | N/A |
| EPS Diluted Continuous Ops | -2.13 | -3.95 | -10.56 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -2.13 | -3.95 | N/A | N/A | N/A |
| EBITDA(a) | $-85,196 | $-46,835 | $-23,024 | $N/A | $N/A |